1
|
Puleo V, Gentili A, Failla G, Melnyk A, Di Tanna G, Ricciardi W, Cascini F. Digital health technologies: a systematic review of their cost-effectiveness. Eur J Public Health 2021. [DOI: 10.1093/eurpub/ckab164.273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Digital health interventions have a potential to improve safety, efficacy and quality of care, reducing waste in healthcare costs. Despite premises, the evidence regarding cost and effectiveness of digital tools in health is scarce and limited.
Objectives: The aim of this systematic review is to summarize the evidence on cost-effectiveness of digital health interventions and to assess whether the studies meet the established quality criteria.
Methods
We queried PubMed, Scopus and Web of Science databases for articles in English published from 1 January 2016 to 31 December 2020 that performed economic evaluations of digital health technologies. The methodological rigorousness of studies was assessed with a well-established checklist (CHEERS). The incremental cost-effectiveness ratio (ICER)was calculated when the reviewed study reported related data but did not express the ICER.
Results
Searches identified 1476 results, 552 of which were selected for abstract and 35 were included in this review. The studies were heterogeneous by country, type of eHealth intervention, method of implementation, and reporting perspectives. The qualitative analysis identified the economic and effectiveness evaluation of seven different types of interventions: fourteen studies on a new telemedicine service; five on telecounseling; five on teletherapy; two on telemonitoring; five on new mobile applications; two on m-health programs; one on digital platforms and one on electronic health records.
Conclusions
Findings on cost-effectiveness of digital interventions showed a growing body of evidence and suggested a generally favorable effect in terms of costs and health outcomes. However, due to the heterogeneity across study methods, the comparison between interventions still remains difficult. Further research based on a standardized approach is needed in order to methodically analyze incremental cost-effectiveness ratios, costs, and health benefits.
Key messages
Digital interventions suggested a favorable effect in terms of costs and health outcomes. Digital health interventions have a potential to improve safety, efficacy and quality of care.
Collapse
Affiliation(s)
- V Puleo
- Department of Life Sciences and Public Health, Section of Hygiene and Public Health, Catholic University of Sacred Heart, Rome, Italy
| | - A Gentili
- Department of Life Sciences and Public Health, Section of Hygiene and Public Health, Catholic University of Sacred Heart, Rome, Italy
| | - G Failla
- Department of Public Health, University of Verona, Verona, Italy
| | - A Melnyk
- Department of Life Sciences and Public Health, Section of Hygiene and Public Health, Catholic University of Sacred Heart, Rome, Italy
| | - G Di Tanna
- Statistics Division, University of New South Wales, Sydney, Australia
| | - W Ricciardi
- Department of Life Sciences and Public Health, Section of Hygiene and Public Health, Catholic University of Sacred Heart, Rome, Italy
| | - F Cascini
- Department of Life Sciences and Public Health, Section of Hygiene and Public Health, Catholic University of Sacred Heart, Rome, Italy
| |
Collapse
|
2
|
Neglia C, Argentiero A, Chitano G, Agnello N, Giolli L, Di Tanna G, Paladini D, Amati A, Marsico A, Caiaffa V, Conte P, La Selva G, Crafa S, Colì G, Ciccarese R, Vigilanza A, Distante C, Argentiero D, Pantile V, Benvenuto M, Di Renzo T, Reale A, Coppola R, Distante A, Colao A, Di Somma C, Migliore A, Auriemma R, Piscitelli P. Diabetes and Obesity as Independent Risk Factors for Osteoporosis in Postmenopausal Women: A Population Study. EUR J INFLAMM 2014. [DOI: 10.1177/1721727x1401200309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
We aimed to analyze bone mineralization and the effect of different risk factors for osteoporosis in postmenopausal women. We studied 2,756 postmenopausal subjects out of ≥10,000 records from the ROIS registry in the frame of the PROF Project, a population study carried out in Salento (Taranto, Brindisi, Lecce) from 2009 to 2012. All subjects were assessed by phalangeal Quantitative Ultrasound (QUS) to evaluate their bone mineralization (assessed by Amplitude Dependent Speed of Sound, AD-SoS) and the association between demineralization and the presence of other conditions or risk factors. Mean age was 64±9.5 years and mean BMI was 28.7±3.5 Kg/m2. Pearson correlation analyses revealed a negative association between bone mineralization (AD-SoS) and BMI (P<0.001). By using multivariate logistic regression analysis, we observed significant values of Odds Ratios of osteoporosis (adjusted for age, physical activity and the use of drugs known to increase the risk of fractures) in subjects with diabetes and obesity: 1.39 (CI: 1,05–1,83) and 1.46 (CI: 1.20–1.78), respectively. A statistically significant linear trend of higher Odds Ratios of osteoporosis was found for increasing values of BMI. The percent change in the odds of vertebral fractures per single SD decrease of AD-SoS was 47% (P<0.001). Diabetes and obesity in postmenopausal women are likely to represent independent risk factors for osteoporosis. Phalangeal QUS showed a good power of predictivity in identifying subjects with vertebral fractures.
Collapse
Affiliation(s)
- C. Neglia
- Department of Biological and Environmental Science and Technology (Di.S.T.E.B.A), University of Salento, Lecce, Italy
| | - A. Argentiero
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - G. Chitano
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - N. Agnello
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - L. Giolli
- E-Campus University, Novedrate, Italy
| | | | - D. Paladini
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - A. Amati
- Local Health Authority, ASL Taranto Taranto, Italy
| | - A. Marsico
- Local Health Authority, ASL Taranto Taranto, Italy
| | - V. Caiaffa
- Local Health Authority, ASL Taranto Taranto, Italy
| | - P. Conte
- Local Health Authority, ASL Taranto Taranto, Italy
| | - G. La Selva
- Local Health Authority, ASL Brindisi, Brindisi, Italy
| | - S. Crafa
- Local Health Authority, ASL Taranto Taranto, Italy
| | - G. Colì
- Local Health Authority, ASL Lecce, Gallipoli Hospital, Gallipoli, Italy
| | - R. Ciccarese
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - A. Vigilanza
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - C. Distante
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - D. Argentiero
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - V. Pantile
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - M. Benvenuto
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | | | | | | | - A. Distante
- ISBEM (Istituto Scientifico Biomedico Euro Mediterraneo), Brindisi, Italy
| | - A. Colao
- Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | | | - A. Migliore
- Fatebenefratelli St. Peter's Hospital- Department of Rheumatology, Rome, Italy
| | - R. Auriemma
- IOS, Southern Italy Hospital Institute, Naples, Italy
- Coleman Ltd, Naples, Italy
| | - P. Piscitelli
- IOS, Southern Italy Hospital Institute, Naples, Italy
- Coleman Ltd, Naples, Italy
| |
Collapse
|
3
|
Piscitelli P, Iolascon G, Di Tanna G, Bizzi E, Chitano G, Argentiero A, Neglia C, Giolli L, Distante A, Gimigliano R, Brandi ML, Migliore A. Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: a 5-year analysis based on hospitalization records. Arthritis Care Res (Hoboken) 2012; 64:1320-7. [PMID: 22511508 DOI: 10.1002/acr.21706] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE To assess the burden of total joint arthroplasties (TJAs) performed for symptomatic hip and knee osteoarthritis (OA) in the Italian population. METHODS We analyzed national hospitalizations and diagnosis-related group databases to compute incidence, annual percent change (APC), direct costs, and working days lost between 2001 and 2005 following TJA due to OA. RESULTS In 2005, we recorded a total of 41,816 (APC +5.4; 95% confidence interval [95% CI] 5.1-5.8) and 44,051 (APC +13.4; 95% CI 13.1-13.8) hip and knee arthroplasties, respectively. Women represented the majority of patients undergoing TJA procedures (female:male ratio 1.7:1 for hip arthroplasties and 2.9:1 for knee arthroplasties). When analyzing the data by age groups, most of the patients were in the age groups 65-74 years and ≥75 years, although the highest increases were observed in those ages <65 years. Revisions accounted for 6,387 (APC +4.9; 95% CI 4.0-5.7) and 2,295 (APC +17.4; 95% CI 15.7-19.2) procedures for the hip and knee, respectively. Loss of working days in patients ages <65 years was estimated between 805,000 and 1 million days. Hospital costs increased from 741 million to 1 billion euros over the 5-year period (from 412 to 538 million euros for hip arthroplasties and from 329 to 517 million euros for knee arthroplasties). Rehabilitation costs increased from 228 to 322 million euros. Postoperative complications were estimated between 3.1 and 4.4 million euros. The average costs per patient were 16,835 and 15,358 euros for hip and knee arthroplasties, respectively. CONCLUSION The socioeconomic burden of TJAs performed for symptomatic OA in Italy is remarkable and calls for the adoption of proper preventive measures.
Collapse
|